- Home
- JAZZ vs PCOR Comparison
JAZZ vs PCOR Comparison
Compare JAZZ & PCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JAZZ | PCOR |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 11.9B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | JAZZ | PCOR |
|---|---|---|
| Price | $168.86 | $68.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 17 |
| Target Price | ★ $207.19 | $90.18 |
| AVG Volume (30 Days) | ★ 1.1M | 967.7K |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,157,832,999.00 | $1,275,450,000.00 |
| Revenue This Year | $6.00 | $16.35 |
| Revenue Next Year | $6.35 | $12.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.14 | ★ 14.94 |
| 52 Week Low | $95.49 | $53.71 |
| 52 Week High | $182.99 | $88.92 |
Technical Indicators
Market Signals| Indicator | JAZZ | PCOR |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 31.72 |
| Support Level | $159.35 | $72.65 |
| Resistance Level | $173.09 | $73.19 |
| Average True Range (ATR) | 5.80 | 2.40 |
| MACD | -0.29 | -0.44 |
| Stochastic Oscillator | 65.44 | 12.07 |
Price Performance
Historical ComparisonAbout JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About PCOR Procore Technologies Inc.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.